Lunsumio 1 mg/mL injection Images

Generic Name: mosunetuzumab

This medication has been identified as Lunsumio 1 mg/mL injection. It is supplied by Genentech, Inc.

Lunsumio is used in the treatment of Follicular Lymphoma and belongs to the drug class bispecific T-cell engagers (BiTE). Lunsumio 1 mg/mL injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Lunsumio

Generic Name

mosunetuzumab

Strength

1 mg/mL injection

Availability

Prescription only

Drug Class

Bispecific T-cell engagers (BiTE)

CSA Schedule

Not a controlled drug

Labeler / Supplier

Genentech, Inc.

National Drug Code (NDC)

50242-0159

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer